Future directions in Focal Segmental Glomerulosclerosis (FSGS) research and management are focused on several key areas. A deeper understanding of the pathogenesis of FSGS, including the roles of genetic factors, podocyte injury, and immune mechanisms, is crucial for developing targeted th